Dorsey Wright & Associates’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
PCMI
AIC
MCM
Dorsey Wright & Associates's NPTN Position: Q3 2020 in Review
Dorsey Wright & Associates sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 941 shares — an estimated $8K sold.
Dorsey Wright & Associates first reported a position in NPTN in Q4 2018 and held it in 3 quarters. The position peaked at $13K in Q4 2018. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.
- Dorsey Wright & Associates reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
- Dorsey Wright & Associates sold 941 NEOPHOTONICS CORP shares in Q3 2020, an estimated $8K.
- Dorsey Wright & Associates first reported a position in NEOPHOTONICS CORP in Q4 2018 and held it in 3 quarters.
- Dorsey Wright & Associates's NEOPHOTONICS CORP position peaked at $13K in Q4 2018.
- 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.
Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.